GlassScriptPhysician profile
Crystal E Smedley
NPI 1720469596
$12,023.30
in general payments reported to CMS, 2019-2025
31 companies · $2,216 in 2025
The $2,216 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $358 · 2021: $6,407 · 2022: $201 · 2023: $665 · 2024: $1,573 · 2025: $2,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,412 · Travel and Lodging: $974 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,412.39 |
| Travel and Lodging | $973.51 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,082.93 | 2021 | |
| Procept Biorobotics Corporation | $1,636.22 | 2024-2025 | Aquabeam System |
| Coloplast Corp | $964.02 | 2019-2025 | Titan |
| Boston Scientific Corporation | $569.64 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700, Ams 700 Cxr Rte Kit |
| Teleflex LLC | $293.77 | 2024-2025 | Urolift, Barrigel |
| Endo Pharmaceuticals INC. | $290.06 | 2020-2024 | Xiaflex, Aveed, Edex |
| Olympus Corporation of The Americas | $207.10 | 2023 | Itind System |
| Abbvie INC. | $199.37 | 2022-2025 | Botox |
| Astellas Pharma US INC | $190.18 | 2022-2025 | Xtandi |
| Antares Pharma, INC. | $171.78 | 2024-2025 | Xyosted |
| Allergan, INC. | $156.69 | 2020-2022 | |
| Tolmar, INC. | $128.48 | 2024-2025 | Eligard |
| Smith+Nephew, INC. | $120.20 | 2019 | |
| Medtronic USA, INC. | $116.80 | 2019-2020 | |
| Janssen Biotech, INC. | $110.48 | 2021-2025 | Erleada |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $92.99 | 2019 | |
| Ferring Pharmaceuticals INC. | $89.26 | 2025 | Adstiladrin |
| Axonics, INC. | $82.21 | 2022-2024 | Axonics, Bulkamid |
| Endo USA, INC. | $73.62 | 2024-2025 | Aveed, Xiaflex, Edex |
| Sumitomo Pharma America, INC. | $70.84 | 2023-2025 | Gemtesa |
| Valencia Technologies Corporation | $64.18 | 2025 | Ecoin Device Kit |
| 180 Medical, INC. | $50.85 | 2020-2023 | Gentlecath |
| Integra Lifesciences Corporation | $50.76 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Karl Storz Endoscopy-America | $49.80 | 2021 | |
| Dendreon Pharmaceuticals LLC | $42.37 | 2022-2025 | Provenge |
| Halozyme INC | $38.76 | 2023 | |
| Myriad Genetic Laboratories, INC. | $21.44 | 2021 | |
| Laborie Medical Technologies Corp. | $19.43 | 2023 | |
| Ethicon US, LLC | $15.11 | 2022 | |
| Urogen Pharma, INC. | $12.63 | 2022 | |
| Medtronic, INC. | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Smedley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.